Latest News for: msk

Edit

Digital Musculoskeletal (MSK) Care Market is Estimated to Cross CAGR of Approximately 18-20% by the End of 2029

Pharmiweb 08 Dec 2025
Global Digital Musculoskeletal (MSK) Care Market Overview ... The global burden of musculoskeletal disorders continues to rise, and this has become a significant factor contributing to the growth of digital MSK care.
Edit

Tyrolpath Adopts MSK-IMPACT®-Flex powered with SOPHiA DDM™ to Expand Precision Oncology in Austria (Sophia Genetics SA)

Public Technologies 05 Dec 2025
We're proud to highlight that Tyrolpath, the largest private pathology lab in western Austria, is the first lab in Austria to adopt MSK-IMPACT®-Flex powered with SOPHiA DDM™, marking a major milestone for precision oncology in the country.
Edit

The 39th annual Miracle on Madison Avenue returns to NYC this Saturday

The Villager 05 Dec 2025
The Society of Memorial Sloan Kettering Cancer Center (MSK) is hard at work this week, as they gear up to host the 39th annual Miracle on Madison Avenue fundraiser ... to pediatric programs at MSK Kids.
Edit

MSK Awards and Appointments October and November 2025 (Memorial Sloan-Kettering Cancer Center)

Public Technologies 02 Dec 2025
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments. ... Across 35 years at MSK, del Rio has guided and inspired countless students who have gone on to become skilled, confident technologists.
Edit

Seguros SURA Colombia Adopts MSK-ACCESS® powered by SOPHiA DDM™ (Sophia Genetics SA)

Public Technologies 19 Nov 2025
We're thrilled to welcome Seguros SURA Colombia to the SOPHiA GENETICS community as they adopt MSK-ACCESS® powered by SOPHiA DDM™ to advance their precision oncology research initiatives ... Learn more about MSK-ACCESS® powered with SOPHiA DDM™.
Edit

Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025

PR Newswire 11 Nov 2025
SOPH), a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM™ on Complete Genomics' DNBSEQ-T1+ sequencing platform.
×